Amanote Research

Amanote Research

    RegisterSign In

Optimization of Fibroblast Growth Factor-1 as an Anabolic Agent for Osteoporosis

doi 10.21236/adb233740
Full Text
Open PDF
Abstract

Available in full text

Date

October 1, 1997

Authors
Wilson H. Burgess
Publisher

Defense Technical Information Center


Related search

FGFR1 (Fibroblast Growth Factor Receptor 1)

Atlas of Genetics and Cytogenetics in Oncology and Haematology
Cancer ResearchOncologyGeneticsHematology
2011English

Anabolic Therapy for Osteoporosis

Women's Health
Medicine
2007English

Egr-1 Activates Basic Fibroblast Growth Factor Transcription

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
1996English

Transforming Growth Factor Beta 1 Regulates Fibroblast Growth Factor 7 Expression in Schwann Cells

Ochsner Journal
Medicine
2019English

Circulating Fibroblast Growth Factor 23 Increases Following Intermittent Parathyroid Hormone (1–34) in Postmenopausal Osteoporosis: Association With Biomarker of Bone Formation

Calcified Tissue International
EndocrinologyOrthopedicsSports MedicineMetabolismDiabetes
2011English

Fibroblast Growth Factor-1 (FGF-1) Loaded Microbeads Enhance Local Capillary Neovascularization

Journal of Surgical Research
Surgery
2010English

Fibroblast Growth Factor Receptor (FGFR)

Science-Business eXchange
2013English

5155214 Basic Fibroblast Growth Factor

International Journal of Biochemistry
1993English

Disruption of Fibroblast Growth Factor Receptor (FGFR) Signaling as an Approach to Prostate Cancer Therapy

2004English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy